Author Archives: Patricia Inacio PhD

Hungary Approves LO2A Eye Drops for Sjögren’s Syndrome Patients

The Hungarian regulatory authority has agreed to extend the label of Wize Pharma‘s LO2A eye drops to include the treatment of dry eye symptoms in Sjögren’s syndrome patients, the company announced. The treatment is marketed in Hungary as Conheal, by Resdevco. While the formulation is registered and marketed for the treatment of dry…

Rare Case of Amyloidosis as Secondary Feature of Sjogren’s Syndrome Described in Report

Although rare, localized amyloidosis can sometimes appear as a consequence of Sjogren’s syndrome, according to a case report from South Korea. The study, “Primary Sjogren syndrome diagnosed simultaneously with localized amyloidosis of the lacrimal gland: A case report,” was published in the journal Medicine. A 45-year-old woman arrived at Pusan National University…

Oral Health of Primary Sjögren’s Patients Seen as Similar to That of Healthy Controls in Small Study

The oral health of patients with primary Sjögren’s syndrome is similar to that of patients with rheumatoid arthritis or healthy individuals, a small study suggests. The study, “Clinical periodontal status and inflammatory cytokines in primary sjogren syndrome and rheumatoid artritis,” was published in The Journal of Periodontology. Primary Sjögren’s…

Infection with Nontuberculous Mycobacteria May Increase Risk for Sjogren’s Syndrome

A history of infection with nontuberculous mycobacteria — linked to chronic pulmonary infections, but unable to cause tuberculosis — may increase the risk for primary Sjögren’s syndrome, according to a large nationwide Taiwanese study. “Although the exact disease mechanism behind [Sjögren’s syndrome] remains elusive, a variety of environmental, genetic and hormonal…